These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 15753451)

  • 1. A randomized trial of frovatriptan for the intermittent prevention of menstrual migraine.
    Adelman JU; Calhoun A
    Neurology; 2005 Mar; 64(5):931; author reply 931. PubMed ID: 15753451
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy of frovatriptan in the acute treatment of menstrually related migraine: analysis of a double-blind, randomized, cross-over, multicenter, Italian, comparative study versus rizatriptan.
    Savi L; Omboni S; Lisotto C; Zanchin G; Ferrari MD; Zava D; Pinessi L
    J Headache Pain; 2011 Dec; 12(6):609-15. PubMed ID: 21842274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and tolerability of short-term preventive frovatriptan: a combined analysis.
    MacGregor EA; Brandes JL; Silberstein S; Jeka S; Czapinski P; Shaw B; Pawsey S
    Headache; 2009 Oct; 49(9):1298-314. PubMed ID: 19788471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Scheduled short-term prevention with frovatriptan for migraine occurring exclusively in association with menstruation.
    Silberstein SD; Berner T; Tobin J; Xiang Q; Campbell JC
    Headache; 2009 Oct; 49(9):1283-97. PubMed ID: 19751371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frovatriptan 2.5 mg plus dexketoprofen (25 mg or 37.5 mg) in menstrually related migraine. Subanalysis from a double-blind, randomized trial.
    Allais G; Bussone G; Tullo V; Cortelli P; Valguarnera F; Barbanti P; Sette G; D'Onofrio F; Curone M; Benedetto C
    Cephalalgia; 2015 Jan; 35(1):45-50. PubMed ID: 25053749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frovatriptan for the acute treatment of migraine and prevention of predictable menstrual migraine.
    Elkind AH; MacGregor EA
    Expert Rev Neurother; 2008 May; 8(5):723-36. PubMed ID: 18457529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of two 6-day frovatriptan dosing regimens used for the short-term prevention of menstrual migraine: A phase I, randomized, double-blind, placebo-controlled, two-period crossover, single-centre study in healthy female volunteers.
    Wade A; Pawsey S; Whale H; Boyce M; Warrington S
    Clin Drug Investig; 2009; 29(5):325-37. PubMed ID: 19366274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frovatriptan vs. transdermal oestrogens or naproxen sodium for the prophylaxis of menstrual migraine.
    Guidotti M; Mauri M; Barrilà C; Guidotti F; Belloni C
    J Headache Pain; 2007 Oct; 8(5):283-8. PubMed ID: 17955167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and tolerability of frovatriptan in the acute treatment of migraine and prevention of menstrual migraine: Results of a new analysis of data from five previously published studies.
    MacGregor EA; Pawsey SP; Campbell JC; Hu X
    Gend Med; 2010 Apr; 7(2):88-108. PubMed ID: 20435272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two center, randomized pilot study of migraine prophylaxis comparing paradigms using pre-emptive frovatriptan or daily topiramate: research and clinical implications.
    Cady RK; Voirin J; Farmer K; Browning R; Beach ME; Tarrasch J
    Headache; 2012 May; 52(5):749-64. PubMed ID: 22188311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized trial of frovatriptan for the intermittent prevention of menstrual migraine.
    Silberstein SD; Elkind AH; Schreiber C; Keywood C
    Neurology; 2004 Jul; 63(2):261-9. PubMed ID: 15277618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frovatriptan as preemptive treatment for fasting-induced migraine.
    Latsko M; Silberstein S; Rosen N
    Headache; 2011 Mar; 51(3):369-374. PubMed ID: 21269298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frovatriptan succinate, a 5-HT1B/1D receptor agonist for migraine.
    Balbisi EA
    Int J Clin Pract; 2004 Jul; 58(7):695-705. PubMed ID: 15311727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frovatriptan versus almotriptan for acute treatment of menstrual migraine: analysis of a double-blind, randomized, cross-over, multicenter, Italian, comparative study.
    Bartolini M; Giamberardino MA; Lisotto C; Martelletti P; Moscato D; Panascia B; Savi L; Pini LA; Sances G; Santoro P; Zanchin G; Omboni S; Ferrari MD; Fierro B; Brighina F
    J Headache Pain; 2012 Jul; 13(5):401-6. PubMed ID: 22592864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frovatriptan review.
    Markus F; Mikko K
    Expert Opin Pharmacother; 2007 Dec; 8(17):3029-33. PubMed ID: 18001261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and tolerability of zolmitriptan oral tablet in the acute treatment of menstrual migraine.
    Tuchman M; Hee A; Emeribe U; Silberstein S
    CNS Drugs; 2006; 20(12):1019-26. PubMed ID: 17140280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral zolmitriptan in the short-term prevention of menstrual migraine: a randomized, placebo-controlled study.
    Tuchman MM; Hee A; Emeribe U; Silberstein S
    CNS Drugs; 2008; 22(10):877-86. PubMed ID: 18788838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A pilot study of oral sumatriptan as intermittent prophylaxis of menstruation-related migraine.
    Newman LC; Lipton RB; Lay CL; Solomon S
    Neurology; 1998 Jul; 51(1):307-9. PubMed ID: 9674831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frovatriptan for acute treatment of migraine associated with menstruation: results from an open-label postmarketing surveillance study.
    Newman LC; Harper S; Jones BA; Campbell J
    J Womens Health (Larchmt); 2009 Aug; 18(8):1265-73. PubMed ID: 19627225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Menstrual migraine: timing is everything.
    Loder E
    Neurology; 2004 Jul; 63(2):202-3. PubMed ID: 15277607
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.